Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Milind Kachare

Plastic and Reconstructive Surgery Saint Louis, MO Medical Doctor

NPI 1518351022 CMS profile 7828979

607 S Lindbergh Blvd, Saint Louis, MO 63131

Open in the dashboard

General payments

$5,906

55 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Milind Kachare of Saint Louis, MO is reported in the CMS Open Payments database as having received $5,906 across 55 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 73rd percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $148 1
2024 General $2,674 15
2023 General $497 10
2022 General $1,505 18
2021 General $1,081 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Milind Kachare
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Milind Kachare were reported at $148. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Milind Kachare Plastic and Reconstructive Surgery median Middle half National median
2019 $0 $335 $121–$1,264 $163
2020 $0 $162 $57–$417 $114
2021 $1,081 $245 $89–$735 $132
2022 $1,505 $325 $120–$932 $149
2023 $497 $343 $129–$999 $160
2024 $2,674 $390 $141–$1,085 $164
2025 $148 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $2,706 15 payments
  2. Baxter Healthcare $562 7 payments
  3. Integra LifeSciences Corporation $551 10 payments
  4. Allergan Inc. $406 4 payments
  5. Stryker Corporation $296 1 payment
  6. TELA Bio, Inc. $242 3 payments
  7. AxoGen $241 2 payments
  8. Sanara MedTech Inc. $236 2 payments
  9. RTI Surgical, Inc $189 3 payments
  10. DePuy Synthes Sales Inc. $146 2 payments
  11. Other $330 6 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $3,870 51 payments
  2. Travel and Lodging $1,740 3 payments
  3. Education $296 1 payment
Products named General payments · program years 2021–2025
  1. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastic Surgery $5,031 24 payments
  2. REVOLVE $2,325 9 payments
  3. STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS $2,325 9 payments
  4. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastics $406 4 payments
  5. SURGIMEND $404 7 payments
  6. NA $296 1 payment
  7. Integra Recon-Skin And Wound $288 5 payments
  8. Integra Recon-Skin And Wound $288 5 payments
  9. INTEGRA DERMAL REGENERATION TEMPLATE $288 5 payments
  10. OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) $242 3 payments
  11. Other $2,495 36 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

55 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic and Reconstructive Surgery in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record